Clinical Research Directory
Browse clinical research sites, groups, and studies.
Vevye + Flarex Combination Therapy for Dry Eye
Sponsor: Canyon City Eyecare
Summary
This study evaluates the safety and efficacy of combination therapy with Vevye (cyclosporine ophthalmic solution) and Flarex (fluorometholone acetate ophthalmic suspension) in adults with moderate to severe dry eye disease. Participants receive Vevye twice daily and Flarex four times daily, with outcomes assessed over a 1-month period.
Official title: Combination Therapy of Vevye and Flarex for Dry Eye Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-04-03
Completion Date
2026-12-31
Last Updated
2026-04-28
Healthy Volunteers
No
Conditions
Interventions
Vevye(Cyclosporine 0.1% Ophthalmic Solution)
Vevye (cyclosporine ophthalmic solution) is administered twice daily (BID) in both eyes for the treatment of dry eye disease.
Flarex
Flarex (fluorometholone acetate ophthalmic suspension) is administered four times daily (QID) in both eyes. Doses are separated from Vevye by approximately 10 minutes.
Locations (1)
Canyon City Eyecare
Azusa, California, United States